Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response

ABSTRACT The Epstein-Barr virus (EBV) efficiently transforms primary B cells. Here, we show that this process starts immediately after cellular exposure to infectious viral particles. Virus binding to B cells led to the activation of intracytoplasmic tyrosine kinases and STAT3. Tegument proteins wit...

ver descrição completa

Detalhes bibliográficos
Principais autores: Francesco Baccianti, Charlène Masson, Susanne Delecluse, Zhe Li, Remy Poirey, Henri-Jacques Delecluse
Formato: Artigo
Idioma:English
Publicado em: American Society for Microbiology 2023-10-01
coleção:mBio
Assuntos:
Acesso em linha:https://journals.asm.org/doi/10.1128/mbio.01784-23
_version_ 1827150333231497216
author Francesco Baccianti
Charlène Masson
Susanne Delecluse
Zhe Li
Remy Poirey
Henri-Jacques Delecluse
author_facet Francesco Baccianti
Charlène Masson
Susanne Delecluse
Zhe Li
Remy Poirey
Henri-Jacques Delecluse
author_sort Francesco Baccianti
collection DOAJ
description ABSTRACT The Epstein-Barr virus (EBV) efficiently transforms primary B cells. Here, we show that this process starts immediately after cellular exposure to infectious viral particles. Virus binding to B cells led to the activation of intracytoplasmic tyrosine kinases and STAT3. Tegument proteins within the virion in turn activated the p38-MK2 pathway upon cell entry, independently of the viral DNA. Engagement of STAT3 and p38/MK2, two pro-inflammatory pathways, was essential for expression of the key EBV transforming gene EBNA2 but also facilitated IL-6 and TNFα release. However, these pathways simultaneously activated ZFP36L1, a stress response protein that targets transcripts with an AU-rich 3′UTR, to reduce IL-6 and TNFα transcription in infected cells. Expression of viral latent proteins after infection amplified the viral effects on p38 and MK2, but also on ZFP36L1, altogether resulting in a transitory and limited increase in IL-6 and TNFα transcription and release. Thus, EBV virions are not merely vehicles that allow injection of the viral DNA into the nucleus but manipulate cellular pathways to initiate transformation while limiting cytokine release. IMPORTANCE The Epstein-Barr virus efficiently infects and transforms B lymphocytes. During this process, infectious viral particles transport the viral genome to the nucleus of target cells. We show here that these complex viral structures serve additional crucial roles by activating transcription of the transforming genes encoded by the virus. We show that components of the infectious particle sequentially activate proinflammatory B lymphocyte signaling pathways that, in turn, activate viral gene expression but also cause cytokine release. However, virus infection activates expression of ZFP36L1, an RNA-binding stress protein that limits the length and the intensity of the cytokine response. Thus, the infectious particles can activate viral gene expression and initiate cellular transformation at the price of a limited immune response.
first_indexed 2024-03-11T08:30:55Z
format Article
id doaj.art-e412be6ce1734366ab5e9d547473783d
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2025-03-20T21:32:24Z
publishDate 2023-10-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-e412be6ce1734366ab5e9d547473783d2024-08-11T18:20:46ZengAmerican Society for MicrobiologymBio2150-75112023-10-0114510.1128/mbio.01784-23Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine responseFrancesco Baccianti0Charlène Masson1Susanne Delecluse2Zhe Li3Remy Poirey4Henri-Jacques Delecluse5Pathogenesis of Virus Associated Tumors, German Cancer Research Center (DKFZ) , Heidelberg, GermanyPathogenesis of Virus Associated Tumors, German Cancer Research Center (DKFZ) , Heidelberg, GermanyPathogenesis of Virus Associated Tumors, German Cancer Research Center (DKFZ) , Heidelberg, GermanyPathogenesis of Virus Associated Tumors, German Cancer Research Center (DKFZ) , Heidelberg, GermanyPathogenesis of Virus Associated Tumors, German Cancer Research Center (DKFZ) , Heidelberg, GermanyPathogenesis of Virus Associated Tumors, German Cancer Research Center (DKFZ) , Heidelberg, GermanyABSTRACT The Epstein-Barr virus (EBV) efficiently transforms primary B cells. Here, we show that this process starts immediately after cellular exposure to infectious viral particles. Virus binding to B cells led to the activation of intracytoplasmic tyrosine kinases and STAT3. Tegument proteins within the virion in turn activated the p38-MK2 pathway upon cell entry, independently of the viral DNA. Engagement of STAT3 and p38/MK2, two pro-inflammatory pathways, was essential for expression of the key EBV transforming gene EBNA2 but also facilitated IL-6 and TNFα release. However, these pathways simultaneously activated ZFP36L1, a stress response protein that targets transcripts with an AU-rich 3′UTR, to reduce IL-6 and TNFα transcription in infected cells. Expression of viral latent proteins after infection amplified the viral effects on p38 and MK2, but also on ZFP36L1, altogether resulting in a transitory and limited increase in IL-6 and TNFα transcription and release. Thus, EBV virions are not merely vehicles that allow injection of the viral DNA into the nucleus but manipulate cellular pathways to initiate transformation while limiting cytokine release. IMPORTANCE The Epstein-Barr virus efficiently infects and transforms B lymphocytes. During this process, infectious viral particles transport the viral genome to the nucleus of target cells. We show here that these complex viral structures serve additional crucial roles by activating transcription of the transforming genes encoded by the virus. We show that components of the infectious particle sequentially activate proinflammatory B lymphocyte signaling pathways that, in turn, activate viral gene expression but also cause cytokine release. However, virus infection activates expression of ZFP36L1, an RNA-binding stress protein that limits the length and the intensity of the cytokine response. Thus, the infectious particles can activate viral gene expression and initiate cellular transformation at the price of a limited immune response.https://journals.asm.org/doi/10.1128/mbio.01784-23Epstein-Barr virusSTAT3p38-MK2ZFP36L1
spellingShingle Francesco Baccianti
Charlène Masson
Susanne Delecluse
Zhe Li
Remy Poirey
Henri-Jacques Delecluse
Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
mBio
Epstein-Barr virus
STAT3
p38-MK2
ZFP36L1
title Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
title_full Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
title_fullStr Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
title_full_unstemmed Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
title_short Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
title_sort epstein barr virus infectious particles initiate b cell transformation and modulate cytokine response
topic Epstein-Barr virus
STAT3
p38-MK2
ZFP36L1
url https://journals.asm.org/doi/10.1128/mbio.01784-23
work_keys_str_mv AT francescobaccianti epsteinbarrvirusinfectiousparticlesinitiatebcelltransformationandmodulatecytokineresponse
AT charlenemasson epsteinbarrvirusinfectiousparticlesinitiatebcelltransformationandmodulatecytokineresponse
AT susannedelecluse epsteinbarrvirusinfectiousparticlesinitiatebcelltransformationandmodulatecytokineresponse
AT zheli epsteinbarrvirusinfectiousparticlesinitiatebcelltransformationandmodulatecytokineresponse
AT remypoirey epsteinbarrvirusinfectiousparticlesinitiatebcelltransformationandmodulatecytokineresponse
AT henrijacquesdelecluse epsteinbarrvirusinfectiousparticlesinitiatebcelltransformationandmodulatecytokineresponse